![logo](/logos/EXAI.webp)
Exscientia plc
NASDAQ:EXAI
4.9 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Exscientia plc |
Symbool | EXAI |
Munteenheid | USD |
Prijs | 4.9 |
Beurswaarde | 622,386,779 |
Dividendpercentage | 0% |
52-weken bereik | 3.8 - 7.91 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Prof. Andrew L. Hopkins DPHIL, FMEDSCI, FRSE FRSC |
Website | https://www.exscientia.ai |
An error occurred while fetching data.
Over Exscientia plc
Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)